Researchers in Japan have developed a predictive model that could improve treatment decisions for advanced pancreatic cancer patients. By combining tumor marker readings with patients' genetic ...

Galleri blood test detects fifty cancers early via cfDNA analysis for adults 50+ with no symptoms, though not a standard ...

Incyte today reports 2025 first quarter financial results, and provides a status update on the Company's clinical development portfolio. "The double-digit revenue growth in the first quarter driven by ...